Patent details

Basic Information

Publication number:

EP2827710

PCT Application Number:

US2013031678

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP137649745

PCT Publication Number:

WO2013142279

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS

French Title of Invention:

POSOLOGIES POUR COMPOSÉS DE LA CLASSE DES ÉCHINOCANDINES

German Title of Invention:

DOSIERSCHEMATA FÜR VERBINDUNGEN DER ECHINOCANDIN-KLASSE

SPC Number:

Dates

Filing date:

14/03/2013

Grant date:

20/11/2019

EP Publication Date:

28/01/2015

PCT Publication Date:

26/09/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

20/11/2019

EP B1 Publication Date:

20/11/2019

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/03/2033

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

11/06/2024

 

 

Name:

NAPP PHARMACEUTICAL GROUP LIMITED

Address:

Unit 191 Cambridge Science Park, Milton Road,, CB4 0GW, Cambridge, United Kingdom (GB)

History of Owners

From:

13/11/2019

To:

11/06/2024

Name:

CIDARA THERAPEUTICS, INC.

Address:

6310 Nancy Ridge Drive Suite 101, San Diego CA 92121, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

24/12/2019

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

POLOWY, Karen

Address:

United States (US)

2

Name:

VAIDYA, Anuradha

Address:

United States (US)

3

Name:

RADHAKRISHNAN, Balasingam

Address:

United States (US)

4

Name:

JAMES, Kenneth, Duke

Address:

United States (US)

Priority

1

Priority Number:

201261612676 P

Priority Date:

19/03/2012

Priority Country:

United States (US)

2

Priority Number:

201261707142 P

Priority Date:

28/09/2012

Priority Country:

United States (US)

Classification

IPC classification:

A01N 37/18; A61K 9/00; A61K 9/08; A61K 38/12; A61K 47/12; A61K 47/26; A61P 31/10; A61K 47/10; A61K 47/18;

Publication

Bulletin

Bulletin Heading:

CO

Bulletin edition number:

2024/09

Publication date:

11/07/2024

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

201947

Publication date:

20/11/2019

Description:

Grant (B1)

2

Issue number:

201952

Publication date:

25/12/2019

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20240000262A

Date Registered:

11/06/2024

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Dennemeyer & Associates S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

NAPP PHARMACEUTICAL GROUP LIMITED

Address:

Unit 191 Cambridge Science Park, Milton Road,, CB4 0GW, Cambridge, United Kingdom (GB)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

31/03/2027

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

19/02/2026

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
11/06/2024	Request For Change	42
11/06/2024	Outgoing Correspondence	1
24/12/2019	Power Of Attorney	1
31/12/2019	Outgoing Correspondence	1